Continuation of epidermal growth factor receptor tyrosine kinase inhibitor treatment prolongs disease control in non-small-cell lung cancers with acquired resistance to EGFR tyrosine kinase inhibitors
2013 ◽
Vol 11
(2)
◽
pp. 161-169
◽
2008 ◽
Vol 56
(3)
◽
pp. 97-103
◽
2013 ◽
Vol 8
(3)
◽
pp. 346-351
◽
2007 ◽
Vol 25
(18)
◽
pp. 2504-2505
◽
2020 ◽
2014 ◽
Vol 35
(8)
◽
pp. 915